$PRPH

ProPhase Labs Inc

  • NASDAQ
  • Consumer Non-Durables
  • Household/Personal Care
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$13.46 ▼-3.374%

Delayed Price

VOLUME

30,787

DAY RANGE

- 13.83

52 WEEK

4.38 - 14.17

Join Discuss about PRPH with like-minded investors

profile
@dros #droscrew
recently

+Initiations 12/20: $ASML $AYLA $BCDA $BEAT $CCB $CMPX $CNNE $CRWD $CTOS $EDSA $ETNB $FNV $NOK $PRPH $SOFI $STM . -Initiations 12/20:

67 Replies 7 👍 10 🔥

Key Metrics

Market Cap

215.72 M

Beta

0.58

Avg. Volume

177.97 K

Shares Outstanding

15.49 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-11

Next Dividend Date

Company Information

ProPhase Labs is a diversified medical science and technology company with deep experience with OTC consumer healthcare products and dietary supplements. The Company is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States. This includes the development and marketing of dietary supplements under the TK Supplements® brand. The Company is also developing ProPhase Diagnostics, Inc. ("ProPhase Diagnostics") to offer COVID-19 and other Respiratory Pathogen Panel (RPP) Molecular tests. The Company also continues to actively pursue strategic investments and acquisition opportunities for other companies, technologies and products.

Website:

HQ: ,

Related News